Neurosonography
Cranial ultrasonography
Cranial ultrasonography (CUS) was introduced into neonatology in the late 1970s and has become an essential diagnostic tool in modern neonatology. The non-invasive nature of ultrasonography makes it an ideal imaging technique in the neonate. In the neonate and young infant, the fontanels and many sutures of the skull are still open, and these can be used as acoustic windows to "look" into the brain.

Therefore, CUS is a reliable tool for detecting congenital and acquired anomalies of the perinatal brain and the most frequently occurring patterns of brain injury in both preterm and full-term neonates.
Purpose of ultrasound screening
- To detect brain injury in at risk babies in order to provide appropriate medical management
- To detect lesions associated with long-term adverse neurodevelopmental outcome
- All infants equal or < 32 weeks gestation
- When clinical situation of the infant deteriorates
- Sudden drop in haemoglobin
- Abnormal neurological signs (e.g. floppy child, large head)
- Neonatal seizures
- All infants with history consistent with hypoxic ischemic insult
- NEC
- Unexplaned poor feeding at term
- Suspected malformations
Time scheduled
- Following admission, as early as possible (if baby stable)
- 1 week
- 3 weeks
- Around term
- Predischarge
- Born prematurely, <32 weeks and /or birth weight <1500g
- Periventricular flaring at discharge
- Leukomalacia
- Meningitis
These include swelling of the brain, bleeding n the brain (intraventricular haemorrhage, IVH), Periventricular Leucomalacia (PVL), and any structural problems.
IVH is more common in premature babies than in full-term infants. Cranial ultrasound can detect most cases of IVH at the first week after delivery. IVH is usually classified into 4 grades, depending on the severity of the bleeding. A grade 1 or 2 bleed has a better outcome for the baby than a grade 3 or 4 bleed.

Fig. 1. Bilateral Grade 3 GM IVH.
![]() |
![]() |
Fig. 2. Ultrasound scan in a premature infant who gradually, over a period of weeks, developed extensive cystic leukomalacia (grade 4)

Screening will be done by head of neonatal unit RCMHP Dr. Pavel Mazmanyan.
Contact tel. (055) 41-65-89 и (010) 53-01-02
Print

